Natera is a leader in genetic testing, offering advanced non-invasive prenatal screening (NIPT) and oncology diagnostics. Its Panorama test detects chromosomal conditions in fetuses, while Signatera monitors cancer recurrence via liquid biopsy. Expectant parents and oncology patients benefit from early, accurate insights, enabling informed healthcare decisions. Natera’s technology enhances personalized medicine through DNA analysis.
Get alerts when this topic surges in newsletters. Free to start.
Sign up freeExplore more trends:Trending Topics ·AI Trends ·Business Trends ·Finance Trends ·Technology Trends